title: [Clinical management of patients with depression and cardiac disease].
abstract: Depression occurs in 15 % to 20 % of patients with acute coronary syndromes and it is also and independent risk factor for morbidity and mortality. Treatment with selective serotonin reuptake inhibitors is effective, safe and may improve survival after myocardial infarction in patients with depression.
authors.affiliation: Guy's Hospital, Londres, Reino Unido. mecamprubi@yahoo.co.uk
authors.forename: Marcelo
authors.initials: M
authors.lastname: Camprubli
authors.forename: Marcos
authors.initials: M
authors.lastname: Suffriti
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000453:epidemiology*; D000068736:Duloxetine Hydrochloride; D006331:Heart Diseases / Q000453:epidemiology*; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D013876:Thiophenes / Q000627:therapeutic use
chemical_list: D000929:Antidepressive Agents, Tricyclic; D013876:Thiophenes; D008803:Mianserin; D000068736:Duloxetine Hydrochloride; D000078785:Mirtazapine